SEC Widens Insider Trading Case Against FDA Chemist
The U.S. Securities and Exchange Commission on Thursday expanded its insider trading claims against a Food and Drug Administration chemist also facing criminal charges, adding allegations of another illegal stock deal....To view the full article, register now.
Already a subscriber? Click here to view full article